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a  b  s  t  r  a  c  t
The aim of this study was to determine the prevalence of osteopenia and osteoporosis in
a  female population, that had bone mineral density (BMD) measured by dual-energy X-
ray  absorptiometry (DXA) in a specialized clinic in the south of Brazil. We conducted a
cross-sectional study including 1871 women that performed scans between January and
December 2012. We conducted a logistic regression analysis with all independent vari-
ables  and outcomes (osteopenia, osteoporosis and fracture risk). According to DXA results,
36.5% of women had normal BMD, 49.8% were diagnosed with osteopenia and 13.7% with
osteoporosis. Menopause and age over 50 years old were risk factors for osteopenia and
osteoporosis while prior hysterectomy and BMI greater than 25 were protective factors. For
the  outcome of fracture at any site the risk factors were age over 50 years old, osteopenia
and osteoporosis (OR = 2.09, 95% CI: 1.28–3.40) and (OR = 2.49, 95% CI: 1.65–3.74), respectively.
©  2014 Elsevier Editora Ltda. All rights reserved.
Fatores  associados  à  osteopenia  e  osteoporose  em  mulheres  submetidas
à  densitometria  óssea
alavras-chave:
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O objetivo deste estudo foi determinar a prevalência de osteopenia e osteoporose em uma
populac¸ão  de mulheres que ﬁzeram exames de densitometria em uma clínica especializada
ensitometria no  sul do Brasil. Nós conduzimos um estudo transversal, incluindo 1.871 mulheres que se
tometria óssea entre janeiro e dezembro de 2012. Foi feita uma análisepidemiologia submeteram à densi
oenc¸as ósseas metabólicas de  regressão logística com todas as variáveis independentes e os desfechos (osteopenia,
osteoporose e risco de fraturas). A densitometria óssea foi diagnosticada como normal em
36,5% das mulheres, 49,8% com osteopenia e 13,7% com osteoporose. Estar na menopausa
 Institution: Universidade do Extremo Sul Catarinense – UNESC, Laboratory of Epidemiology.
∗ Corresponding author.
E-mail: mir@unesc.net (M.I. da Rosa).
ttp://dx.doi.org/10.1016/j.rbre.2014.08.011
255-5021/© 2014 Elsevier Editora Ltda. All rights reserved.
224  r e v b r a s r e u m a t o l . 2 0 1 5;5 5(3):223–228
e ter mais de 50 anos foram fatores de risco para osteopenia e osteoporose, enquanto ter
feito histerectomia e apresentar índice de massa corporal (IMC) maior do que 25 foram
fatores de protec¸ão. Para o desfecho fratura em qualquer sítio, os fatores associados foram
idade acima de 50 anos e osteopenia ou osteoporose, (OR = 2,09, intervalo de conﬁanc¸a [IC]:
1,28-3, 95%, 40) e (OR = 2,49, 95% CI: 1,65-3, 74), respectivamente.
© 2014 Elsevier Editora Ltda. Todos os direitos reservados.Introduction
Osteoporosis is a systemic skeletal disease characterized by
low bone mass and micro architectural deterioration of the
bone tissue, resulting in increased risk of fracture due to bone
fragility.1 It was recently acknowledged as one of the main
public health issues of developed countries.2
Osteoporosis is diagnosed by measuring the bone mineral
density (BMD); a bone density that is 2.5 standard deviations
(SD) or more  below the young adult mean value (t-score <−2.5)
indicates osteoporosis. Patients with bone density between 1
and 2.5 SD below average (t-score −1 to −2.5) are said to have
osteopenia.3
In women, BMD  decreases with age, presenting sharp drop
during menopause. It is estimated that one in every two
women in the UK from the age of 50 will suffer some kind
of fracture during the remainder of her life.4
With increasing life expectancy and an aging population,
it is anticipated that the impact of osteoporosis in the com-
ing years will have a signiﬁcant increase.5 We should expect
an economic burden for current and future public health sys-
tem due to the high prevalence of osteoporosis and resulting
fractures.6
The aim of this study was to determine the prevalence
and factors associated with osteopenia and osteoporosis in
women who  have undergone bone mineral density test in a
specialized service.
Methods
A cross-sectional study was made with 1871 women under-
going bone mineral density test in a specialized clinic from
January 2012 to December 2012. The project was approved by
the Research Ethics Committee of Universidade Extremo Sul
Catarinense under Protocol No. 829 392 012.
Osteopenia and osteoporosis were diagnosed by Dual-
energy X-ray absorptiometry (DXA), allowing the BMD  to be
measured with the GE Lunar Prodigy Primo equipment with
software Encore version 13.20. The Lunar Prodigy series
showed clinical accuracy even 40% higher compared to other
systems. A study suggests that BMD  measurement error is
between 5% and 8%.7
DXA is considered the gold standard for measuring BMD
and diagnosing osteopenia/osteoporosis. DXA results are pre-
2sented by (1) absolute BMD  values (g/cm ): absolute values
are important because they are used to monitor changes in
BMD  over time; (2) t-score, calculated in SD, taking as refer-
ence the mean BMD  of peak bone mass in young adults. Thediagnostic criteria proposed by the World Health Organization
(WHO) in 1994, based on the following data: up to −1.0 SD,
normal, from −1.1 to −2.49 SD, osteopenia, and below −2.5
SD, osteoporosis8; (3) Z-score, calculated on SD, taking as ref-
erence the mean BMD expected for individuals of same age,
ethnicity and gender.
It is important to recognize that the DXA results described
here are only valid when strict criteria for the exam, quality
control and analysis of the images are observed. The profes-
sionals responsible for the acquisition of images, as well as for
analyzing and interpreting them must act in accordance with
recognized professional qualiﬁcation programs in the country.
The incorrect application of the method limits its use, as in all
imaging tests.
General data were taken from the densitometry report
and included measurement of weight and height, age,
BMI, previous fractures, calcium intake, thyroid medication,
menopause, hormone replacement therapy, symptoms of
menopause, hysterectomy and oophorectomy. Age was cat-
egorized into percentiles: (1) 25th percentile: aged 51 years or
less, (2) between 25th and 50th percentile: aged 52–57 years,
(3) between 50th and 75th percentile: aged 58–65 years and
(4) above the 75th percentile: aged 66 years or older. Other
qualitative variables were dichotomized.
BMI  was calculated using the formula weight (kg)/height2
(m). The DXA data collected included BMD  values (g/cm2) of
the femur neck, preferably the right one, the total femur and
the mean value of the lumbar vertebrae (L1-L4).
Descriptive analysis of all variables was performed. A
bivariate analysis was performed using the Pearson’s chi-
square test.
In the model building process, we observed the importance
of each component through the likelihood ratio test. The −2log
likelihood (deviance) value, which is a measure to determine
how well the model ﬁts the data, was used. Estimates per inter-
val were calculated using 95% conﬁdence level. All variables
with p < 0.25 (univariate analysis) were candidates to enter the
model, according to the method of Hosmer and Lemeshow.
Only p < 0.05 variables remained in the model. In case any bio-
logically important change was observed in the coefﬁcient of
estimated risk factor, comparing models with and without the
risk factor, it was considered that the covariate would be a
confounding factor, and if so, should remain in the model,
even if its own coefﬁcient was not signiﬁcant. The method
used to build the multivariable logistic regression model was
the backward method, in which all the variables selected by
the researchers enter the model, and selection is made by
removing the least signiﬁcant variable, one at a time, in an
automatic sequence mode, based on statistical criteria. The
estimates per interval were calculated using 95% conﬁdence
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Table 1 – Characteristics of the women that performed
DXA scans from January to December, 2012, presented
as frequency (%) or average (± SD).
Variable Average ± SD or n (%)
Age (years old) 59.2 ± 10.5
Weight (kg) 68.7  ± 12.8
Height (m) 1.57  ± 0.06
Femoral neck BMD 0.89 ± 0.27 t score: −1.03
Total femoral BMD 0.93 ± 0.15 t score: −0.59
Lumbar spine BMD 1.0 ± 0.17 t score: −0.75
BMI (kg/m2) 27.7 ± 5.0
≥24.9 kg/m2 592 (34.9)
≥25 kg/m2 1104 (65.1)
Fractures (n = 104)
Forearm 45 (43.3)
Ribs 24 (23.0)
Femur 22 (21.2)
Spine 13 (12.5)
Calcium intake
Yes 595 (31.9)
No 1273 (68.1)
DXA diagnosis
Normal 682 (36.5)
Osteopenia 932 (49.8)
Osteoporosis 257 (13.7)
Use of thyroid medication
Yes 412 (22.1)
No 1455 (77.9)
Hysterectomy
Yes 461 (24.9)
No 1392 (75.1)
Oophorectomy
Yes 332 (18.1)
No 1506 (81.9)
DXA, dual-energy X-ray absorptiometry; SD, standard deviation; n,
number of individuals; BMD, bone mineral density; BMI, body mass
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lence of osteoporosis to be 33% and osteoporotic fractures ofindex.
evel. Interactions between variables were tested, and they
ere all nonsigniﬁcant at a 5% level of signiﬁcance.
Statistical analysis was performed using the Statistical
ackage for Social Sciences (SPSS) version 18.0.
esults
he sample consisted of 1871 women who underwent DXA
can in a specialized private clinic in south of Santa Cata-
ina. The average age was 59.2 ± 10.5 years, mean weight
f 68.7 ± 12.8 and height of 1.57 ± 0.06. The mean BMI was
7.7 ± 5.0, 65.1% had a BMI  > 25. The prevalence of fractures
t any site was of 5.5%; the forearm and ribs being the most
revalent (Table 1). It was found that 31.9% of women were tak-
ng calcium, and 22.1% were on thyroid medication, 24.9% had
reviously had a hysterectomy, and 18.1%, an oophorectomy
Table 1).According to the bone mineral density test diagnosis, 36.5%
f women were normal, 49.8% had osteopenia and 13.7% had
steoporosis (Table 1). 5;5 5(3):223–228 225
Table 2 shows the prevalence of bone mass density in differ-
ent subgroups, as well as the analysis of statistical signiﬁcance
using the chi-square test. The linear increase in osteopenia
and osteoporosis was observed with advancing age (p < 0.001).
The BMI, however, was inversely associated with reduced BMD
(p < 0.001), i.e., women with higher BMI  had less osteopenia or
osteoporosis.
The correlations between the BMD  measured at the spine,
femur and femoral neck and the BMI were (r = −0.133, p < 0.001,
r = 0.590 p < 0.001 and r = 0.258, p < 0.001), respectively.
The BMD at all sites had negative correlation with age
(femoral neck r = −0.220, r = −0.337 total femur and lumbar
spine r = −0.015, p < 0.001).
The multivariate regression had the following outcomes:
osteoporosis, osteopenia and any fracture.
Table 3 shows the ﬁnal logistic regression model for the ﬁrst
two outcomes, including the variables mean dichotomized
age, menopause, BMI and hysterectomy. One can observe
increased risk of osteoporosis for the variables age and
menopause. Protection was found with an increased BMI  and
hysterectomy.
Table 4 shows the ﬁnal fracture model, in which being older
than 50 years old and presenting osteopenia/osteoporosis
increase the chances of fractures at any site in 2.09 and 2.49,
respectively, when compared to women aged 49 years or less
and women with normal BMD.
Discussion
Our study used data from a clinic specialized in the diagnosis
of osteoporosis, so the prevalence of osteopenia and osteo-
porosis cannot be extended to the general population, being
restricted to a group of women referred for a DXA  scan. In this
case, the prevalence of osteoporosis should be overrated in
relation to other population groups.
According to the DXA results, 36.5% of women had normal
BMD,  49.8% were diagnosed with osteopenia and 13.7% with
osteoporosis. The prevalence of osteopenia and osteoporosis
found in our study showed a linear increase with age in the
four age percentiles of the population studied.
The prevalence found in this study was lower than that
found in the literature on similar studies conducted before
the year 2000. In a study that assessed the prevalence of osteo-
porosis in Brazilian women, above the age of 50, and referred
for bone density test, this prevalence was of 40%.9 In the
United States, a study with 600 patients at Wayne State Uni-
versity in Detroit, found a prevalence of 52%.10
The NHANES III study conducted between 1988 and 1994
by the Centers for Disease Control and Prevention gathered
3311 postmenopausal women above the age of 50 for proxi-
mal  femur BMD  examinations. The prevalence of osteoporosis
and osteopenia veriﬁed was 18% and 50%, respectively.11 In
Sao Paulo state, a cross-sectional study with 4332 women over
the age of 40, in a primary care service, found the preva-11.5%(p  < 0.05),12 while another study with 627 women over
the age of 50 showed prevalence of osteoporosis in the lumbar
spine and in femoral neck of 28.8% and 18.8%, respectively.13
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Table 2 – Prevalence of bone mineral mass density in patients subgroups.
Variable BMD
Normal Osteopenia Osteoporosis p-valuea
n (%) n (%) n (%) Osteopenia vs.
normal
Osteoporosis
vs.  normal
Total 682 (36.5) 932 (49.8) 357 (13.7)
Age 16.4 (10) 19.7 (12) <0.001 <0.001
Up to 51 264 (55.9) 193 (40.8) 16 (3.3)
52–57 196 (42.6) 213 (46.3) 51 (11.1)
58–65 143 (30.4) 256 (54.4) 71 (15.2)
66 or older 79 (16.9) 270 (57.7) 119 (25.4)
BMI <0.001 <0.001
Up to 24.9 164 (27.7) 304 (51.4) 124 (20.9)
25–29.9 219 (38.8) 277 (49.2) 68 (12.0)
30–34.9 166 (45.1) 172 (46.7) 30 (8.2)
35–39.9 45 (40.2) 54 (48.2) 13 (11.6)
40 or more 18 (41.9) 20 (46.5) 5 (11.6)
Menopause <0.001 <0.001
Yes 481 (71.0) 797 (86.2) 235 (92.5)
No 196 (29) 128 (13.8) 19 (7.5)
HRT
Yes 105 (15.8) 147 (16.3) 35 (13.8) 0.770 0.470
No 561 (84.2) 754 (83.7) 218 (86.2)
Fractures 0.002 <0.001
Yes 22 (3.2) 63 (6.8) 34 (13.3)
No 659 (96.8) 865 (93.2) 222 (86.7)
ss inda p-value, chi-square test; BMD, bone mineral density; BMI, body ma
In both male and female individuals, there is a balance
between bone formation and resorption, but this becomes pro-
gressively negative with increasing age. Age-related bone loss
begins immediately after the peak bone mass, but most of
the bone loss occurs after the age of 65. Men, however, are
less likely to develop osteoporosis than women, for two rea-
sons: ﬁrst, they gain more  bone mass during puberty and,
Table 3 – Logistic regression model, considering the
outcome variable – osteopenia vs. normal and
osteoporosis vs. normal.
Variable Adjusted OR (CI 95%)
Osteopenia Osteoporosis
Age
50 years or older 2.80 (2.20–3.57) 6.34 (4.36–9.23)
Up to 49 years old 1.00 1.00
BMI
25 or more 0.46 (0.36–0.59) 0.22 (0.15–0.32)
Up to 24.9 1.00 1.00
Hysterectomy
Yes 0.67 (0.52–0.87) 0.61 (0.41–0.92)
No 1.00 1.00
Menopause
Yes 2.17 (1.63–2.88) 3.33 (1.92–5.77)
No 1.00 1.00
CI, conﬁdence interval; BMI, body mass index.ex; HRT, hormone replacement therapy.
second, they lose less bone mass during aging, because, unlike
women, men  do not experience a sudden loss of estrogen.
Elderly living at retirement homes are at greater risk. Eighty-
ﬁve percent of women living in nursing homes over age 80
have osteoporosis.14
Our results showed a linear increase of osteopenia and
osteoporosis with advancing age. In addition to the effects
on bone mass, the aging also increases the risk of fractures,
regardless of the bone mass, and an increase of 20 years of age
means a fourfold risk of fractures.15
Oxidative stress (OS) is a common mechanism of pathogen-
esis of various degenerative diseases associated with aging,
16,17including osteoporosis. An increase in reactive oxygen
species (ROS) was implicated in decreased bone formation
associated with advancing age, as well as increased resorption
Table 4 – Final logistic regression model, considering the
outcome variable – any fracture.
Variable Adjusted OR (CI 95%)
Age
50 years or older 2.09 (1.28–3.40)
Up to 49 years old 1.00
BMD
Osteopenia/osteoporosis 2.49 (1.65–3.74)
Normal 1.00
BMD, bone mineral density; CI, conﬁdence interval.
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ssociated with estrogen deﬁciency.16 In line with this evi-
ence, increased ROS production in osteoblasts stimulates
poptosis and decreased bone formation. As of the fourth
ecade, the bone formation is lower than the resorption.18
erum levels of the insulin-like growth hormone that mod-
lates the effect of the GH in the bone also decrease with
ge.19
Our study showed a higher prevalence of forearm, rib, hip
nd spine fractures, respectively. According to the literature,
he vertebral fracture is the most common clinical manifes-
ation of osteoporosis. Most of these fractures (about two
hirds) are asymptomatic, diagnosed as an incidental ﬁnding
n X-ray.20 Hip fractures are relatively common in osteo-
orosis and affects 15% of women and 5% of men  at the
ge of 80. Subchondral insufﬁciency fractures of the femoral
ead, resulting in osteopenia, can lead to rapid loss of car-
ilage and space-destructive osteoarthritis.21 In addition to
hat, fractures of the distal radius (Colles’ fractures) may also
ccur and are more  common in women after menopause,
hile the risk of hip fracture increases exponentially with
ge.
Our results show an inverse correlation between the BMI
nd the risk of osteopenia and osteoporosis. Published studies
how that low body weight (less than 58 kg) is associated with
n increased risk of osteoporosis and fractures. Weight losses
fter the age of 50 in women increases the risk of hip fracture,
hile weight gains decreases this risk.22,23
Menopause was also a risk factor with statistical signif-
cance in our study. The rate of bone loss in women with
ostmenopausal hypoestrogenism is probably around 0.5%
nd 1.5% per year, with a small percentage of women who
re “fast bone losers” and can lose 3%–5% of bone mass per
ear. The rate of bone loss is highly dependent on hormonal
actors, environmental and genetic factors. In a longitudi-
al study with 272 healthy pre- and perimenopausal women,
here was no bone loss in women beyond the menopause,
hile an accelerated bone loss was observed in the 2–3 years
rior to the cessation of menstruation, with signiﬁcant cor-
elation between the rate of bone lost and the elevation
f follicle-stimulating hormone (FSH) and markers of bone
etabolism.24–26
We  also found that hysterectomy would be a protective
actor for osteopenia and could not ﬁnd a plausible expla-
ation for this protection, since it goes against the literature,
hich reports a decrease in bone mass after hysterectomy.27–29
his variable is independent of the oophorectomy, which was
nalyzed apart and showed no statistical signiﬁcance. This
nalysis may be biased, since confounding factors, such as
he lifestyle and the reproductive history of the patients, were
ot controlled.
onclusion
ur study showed that the prevalence of osteopenia is greater
han that of osteoporosis and that old age and menopause
re risk factors for both outcomes, while BMI  above 25 and
rior hysterectomy were protective factors. For the fracture
utcome, the statistically signiﬁcant risks were age above 50
ears old and osteopenia or osteoporosis.
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